The report will be for the fiscal period ending February 28th, 2019. Analysts expect earnings to be released on April 3rd, 2019. For the twelve months ended February 28th, 2018 vs February 28th, 2017, CarMax reported revenue of $17,120.21MM vs $15,875.12MM (up 7.84%) and analysts estimated basic earnings per share $3.64 vs $3.29 (up 10.64%). (TIF) report, download it here: įor the three months ended November 30th, 2018 vs November 30th, 2017, CarMax reported revenue of $4,295.87MM vs $4,107.02MM (up 4.60%) and analysts estimated basic earnings per share $1.09 vs $0.82 (up 32.93%). The estimated EPS forecast for the next fiscal year is $4.87 and is expected to report on March 15th, 2019. The reported EPS for the same quarter last year was $1.67. The report will be for the fiscal period ending January 31st, 2019. Analysts expect earnings to be released on March 15th, 2019.
For the twelve months ended January 31st, 2018 vs January 31st, 2017, Tiffany reported revenue of $4,169.80MM vs $4,001.80MM (up 4.20%) and analysts estimated basic earnings per share $2.97 vs $3.57 (down 16.81%). All amounts in millions (MM), except per share amounts.įor the three months ended October 31st, 2018 vs October 31st, 2017, Tiffany reported revenue of $1,012.40MM vs $976.20MM (up 3.71%) and analysts estimated basic earnings per share $0.78 vs $0.81 (down 3.70%).
Percentage calculations are performed after rounding. All information in this release was accessed January 25th, 2019. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Several excerpts from the recently released reports are available to today's readers below. ( CATB) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward.
( CLF), and Catabasis Pharmaceuticals, Inc. The new research reports from Market Source Research, available for free download at the links above, examine Tiffany & Co. (You may have to copy and paste the link into your browser and hit the key)
0 kommentar(er)
